Mingjin Yan

900 citations

15 papers · 636 indexed · h-index 10

Impact in

Virology top 5%
- HIV Research and Treatment
Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in ⓘ

Infectious Diseases 7
- HIV/AIDS drug development and treatment 7
- HIV/AIDS Research and Interventions 2
Virology 6
- HIV Research and Treatment 6

Co-authors: Keying Ye (2 shared papers)Andrew Cheng (7 shared papers)Atul R. Mahableshwarkar (2 shared papers)David V. Sheehan (2 shared papers)Paula L. Jacobsen (2 shared papers)Joel E. Gallant (4 shared papers)Martin S. Rhee (4 shared papers)Michael E. Abram (3 shared papers)
Journals: JAIDS Journal of Acquired Immune Deficiency Syndromes (3 papers)Journal of Clinical Oncology (2 papers)European Neuropsychopharmacology (2 papers)The Lancet HIV (2 papers)HIV Clinical Trials (1 paper)
Partner nations: United States United Kingdom France

In The Last Decade

Mingjin Yan

15 papers receiving 619 citations

Peers

Countries citing papers authored by Mingjin Yan

Since Specialization

Citations

This map shows the geographic impact of Mingjin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingjin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingjin Yan more than expected).

Fields of papers citing papers by Mingjin Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingjin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingjin Yan. The network helps show where Mingjin Yan may publish in the future.

Co-authors

The 25 scholars most cited alongside Mingjin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mingjin Yan Line = papers co-authored together Mingjin Yan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work
1	Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate given as fixed-dose combinations containing emtricitabine as backbones for treatment of HIV-1 infection in virologically suppressed adults: a randomised, double-blind, active-controlled phase 3 trial The Lancet HIV ·Joel E. Gallant, Eric S. Daar, François Raffi, Cynthia Brinson, Peter Ruane, Edwin DeJesus, Margaret Johnson, Nathan Clumeck, Olayemi Osiyemi, D Ward, Javier O Morales-Ramirez, Mingjin Yan, Michael E. Abram, Andrew Plummer, Andrew Cheng, Martin S. Rhee	2016	127
2	Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate in the First Protease Inhibitor–Based Single-Tablet Regimen for Initial HIV-1 Therapy JAIDS Journal of Acquired Immune Deficiency Syndromes ·Anthony Mills, Gordon Crofoot, Cheryl McDonald, Peter Shalit, Jason Flamm, Joseph Gathe, Anita Scribner, David Shamblaw, Michael S. Saag, Huyen Cao, Hal Martin, Moupali Das, Anne Thomas, Hui C. Liu, Mingjin Yan, Christian Callebaut, Joseph M. Custodio, Andrew Cheng, Scott McCallister	2015	121
3	Determining the Number of Clusters Using the Weighted Gap Statistic Biometrics ·Mingjin Yan, Keying Ye	2007	101
4	Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults JAIDS Journal of Acquired Immune Deficiency Syndromes ·François Raffi, Chloe Orkin, Amanda Clarke, Laurence Slama, Joel E. Gallant, Eric S. Daar, Keith Henry, Jorge Santana‐Bagur, David Stein, Nicholaos Bellos, Anthony Scarsella, Mingjin Yan, Michael E. Abram, Andrew Cheng, Martin S. Rhee	2017	60
5	Vortioxetine (Lu AA21004) in generalized anxiety disorder: Results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial European Neuropsychopharmacology ·Leszek Bidzan, Atul R. Mahableshwarkar, Paula L. Jacobsen, Mingjin Yan, David V. Sheehan	2012	59
6	Vortioxetine (Lu AA21004) 5 mg in generalized anxiety disorder: Results of an 8-week randomized, double-blind, placebo-controlled clinical trial in the United States European Neuropsychopharmacology ·Anthony J. Rothschild, Atul R. Mahableshwarkar, Paula L. Jacobsen, Mingjin Yan, David V. Sheehan	2012	47
7	A Randomized, Open-Label Trial to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Darunavir in Treatment-Experienced HIV-1-Infected Adults JAIDS Journal of Acquired Immune Deficiency Syndromes ·Gregory Huhn, Pablo Tebas, Joel E. Gallant, Timothy Wilkin, Andrew Cheng, Mingjin Yan, Lijie Zhong, Christian Callebaut, Joseph M. Custodio, Marshall W. Fordyce, Moupali Das, Scott McCallister	2016	41
8	Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial HIV Clinical Trials ·Frank A. Post, Yazdan Yazdanpanah, Gabriel Schembri, Adriano Lazzarin, Jacques Reynes, Franco Maggiolo, Mingjin Yan, Michael E. Abram, Cecilia Tran‐Muchowski, Andrew Cheng, Martin S. Rhee	2017	24
9	Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial The Lancet HIV ·Alan Winston, Frank A. Post, Edwin DeJesus, Daniel Podzamczer, Giovanni Di Perri, Vicente Estrada, François Raffi, Peter Ruane, Paula Peyrani, Gordon Crofoot, Patrick Mallon, Francesco Castelli, Mingjin Yan, Stephanie Cox, Moupali Das, Andrew Cheng, Martin S. Rhee	2018	20
10	Valproic acid‐induced fetal malformations are reduced by maternal immune stimulation with granulocyte‐macrophage colony‐stimulating factor or interferon‐γ The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology ·Terry C. Hrubec, Mingjin Yan, Keying Ye, Carolyn M. Salafia, Steven D. Holladay	2006	20
11	SGN-B6A, an integrin beta-6 (ITGB6)-targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors: Updated results from a phase 1 study (SGNB6A-001). Journal of Clinical Oncology ·Antoine Hollebecque, Juanita Lopez, Sarina A. Piha‐Paul, Afshin Dowlati, Amita Patnaik, Vladimir Galvao, Bruno Bockorny, Kartik Sehgal, Ed Kingsley, Rachel E. Sanborn, Cesar A. Perez, Solange Peters, Mingjin Yan, Natalya Nazarenko, Emiliano Calvo	2023	7
12	Strategic Simplification: The Efficacy and Safety of Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) plus Darunavir (DRV) in Treatment-Experienced HIV-1 Infected Adults (NCT01968551) Open Forum Infectious Diseases ·Gregory Huhn, Pablo Tebas, Joel E. Gallant, Timothy Wilkin, Andrew Cheng, Mingjin Yan, Christian Callebaut, Marshall W. Fordyce, Moupali Das, Scott McCallister	2015	4
13	Phase 1 study of SGN-PDL1V, a novel, investigational vedotin antibody–drug conjugate directed to PD-L1, in patients with advanced solid tumors (SGNPDL1V-001, trial in progress). Journal of Clinical Oncology ·Amita Patnaik, Justin Call, Anna Spreafico, Lisle Nabell, Mingjin Yan, Andres Forero-Torres, Maura L. Gillison	2022	3
14	235P Efficacy and safety of first-line therapy with fulvestrant or exemestane for postmenopausal ER+/HER2- advanced breast cancer patients after adjuvant nonsteroidal aromatase inhibitor treatment: A randomized, open-label, multicenter study Annals of Oncology ·J. Wang, B. Xu, Lei Cai, Yuxin Song, Lovellen Kang, Tie Sun, Y K Onno Teng, Zhong Sheng Tong, H. Li, Quchang Ouyang, Shunyu Cui, Mingjin Yan, Q. Chen, Yongkai Yin, Qiuhua Sun, Ning Liao, Juan Feng, X. Wang	2021	1
15	Abstract CT078: Phase 1 study of SGN-EGFRd2 in solid tumors (SGNEGFRd2-001) Cancer Research ·Hirva Mamdani, J. Randolph Hecht, Rachel E. Sanborn, Maria Corinna Palanca-Wessels, Mingjin Yan, Martin Gutierrez, David L. Bajor	2024	1

About Mingjin Yan

Mingjin Yan is a scholar working on Infectious Diseases, Virology, Emergency Medicine, Oncology and Pharmacology, having authored 15 papers that have together received 636 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (6 papers), HIV-related health complications and treatments (6 papers), HIV/AIDS Research and Interventions (2 papers), Treatment of Major Depression (2 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (2 papers), Cancer Treatment and Pharmacology (1 paper) and Mental Health Research Topics (1 paper). The work is most often cited by research in Virology (211 citations), Infectious Diseases (362 citations), Emergency Medicine (186 citations), Biological Psychiatry (24 citations) and Experimental and Cognitive Psychology (72 citations). Mingjin Yan has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Keying Ye, Andrew Cheng, Atul R. Mahableshwarkar, David V. Sheehan, Paula L. Jacobsen, Joel E. Gallant, Martin S. Rhee, Michael E. Abram, François Raffi and Leszek Bidzan. Their work appears in journals such as JAIDS Journal of Acquired Immune Deficiency Syndromes, Journal of Clinical Oncology, European Neuropsychopharmacology, The Lancet HIV and HIV Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact